•Tripartite Interplay of Epithelial, Immune, and Microbiota Dysregulation in Crohn's Disease: Mechanisms and Translational Strategies
•Targeting IL-23p19 in Inflammatory Bowel Disease: The Road Ahead
•Antifungal therapy reshapes the gut microbiota in IBD
•Induction of mucosal healing by biologics is topographically comparable in proximal and distal small bowel Crohn's disease
•Enterotype-based stratification identifies clinically distinct microbial subtypes in inflammatory bowel disease